does retatrutide cause cancer Pharmacological Dissection Identifies Overcomes the Therapeutic Barrier of Obese TNBC Treatments through Suppressing the Interplay between Glycosylation and Ubiquitylation of YAP STUDY: Novel “Triagonist” Retatrutide Resolved

Is GLP-1 Safe If I Do Not Have Diabetes

Instead of reserving GLP-1 receptor agonists for later stages, emerging evidence suggests starting sooner may improve outcomes and Read More Managing Rapid Improvement on GLP-1 Therapy: When to Adjust the Rest of the Regimen May 6, 2026 Articles, Blood Glucose Control, Blood Glucose Control, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,535 views Rapid glycemic improvement with GLP-1 therapy is one of the most powerful benefits of modern diabetes care, but it can also create new clinical challenges

More research is needed to study potential short- and long-term risks across a broader population, which is why GLP-1s are generally not recommended for breastfeeding women

Central effects of glucagon-like peptide-1 on cold-restraint stress-induced gastric mucosal lesions

Additional Information

One meta-analysis showed that just 1 gram of concentrated berberine significantly lowered cholesterol, BMI, weight, fasting glucose, HbA1C and other metabolic markers